• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov8
Ernexa Therapeutics released FY2025 Q3 earnings on November 7, 2025 (EST), actual revenue USD 0, actual EPS USD -0.1507
04:00
Ernexa Therapeutics released FY2025 9 Months Earnings on November 7, 2025 (EST), actual revenue USD 0, actual EPS USD -3.064
04:00
Aug14
Ernexa Therapeutics released FY2025 Semi-Annual earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -2.6089
03:00
Ernexa Therapeutics released FY2025 Q2 earnings on August 13 (EST), actual revenue USD 0, actual EPS USD -0.6076
03:00
Jun25
Ernexa Hires Two Doctors for Ovarian Cancer and Autoimmune Disease Projects
13:03
Jun12
Charles Cherington Reports Acquisition of Ernexa Therapeutics Inc. Common Stock
00:35

Schedules & Filings

Schedules
Filings
Nov7
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -1.24 M, EPS -0.1507

Aug13
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -3.147 M, EPS -0.6076

Jun12
Reverse Stock Split(EST)

1-for-15 Reverse Stock Split

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ASPC
24.010
+78.91%
+10.590
PCLA
0.4050
+74.49%
+0.173
DTCK
0.3951
+66.08%
+0.157
SOPA
1.820
+58.26%
+0.670
ECDA
1.150
+46.50%
+0.365
GAUZ
1.470
+44.12%
+0.450
CELG.RT
0.0698
+39.60%
+0.020
ASPCR
0.2500
+38.89%
+0.070
PAVS
2.170
+37.34%
+0.590
CUE
0.3248
+34.77%
+0.084
View More